This bill directs the President to impose visa and admission sanctions on any foreign person the federal government determines has performed or facilitated chemical or surgical treatments the text labels “mutilations” of United States minors. The triggers include membership in the World Professional Association for Transgender Health (WPATH), licensed physicians who perform or prescribe specified interventions for U.S. citizens or lawful permanent resident children under 18, and owners or operators of foreign clinics or pharmacies that provide those interventions.
Practically, the statute makes covered foreign persons inadmissible, ineligible for visas, and subject to immediate cancellation of any existing U.S. visas. It also requires the Secretary of State to accept public submissions identifying foreign persons, sets a whistleblower carve‑out, permits a presidential national‑security waiver, and directs a 180‑day report to Congress on implementation.
At a Glance
What It Does
The bill requires the President to designate as inadmissible foreign persons who are WPATH members, who as licensed clinicians performed or facilitated specified chemical or surgical interventions on U.S. minors, or who run institutions that provide those interventions. Designated persons are barred from visas and face immediate revocation of any current entry documents.
Who It Affects
Foreign licensed clinicians, clinic owners, pharmacists, and other medical personnel who provide puberty blockers, cross‑sex hormones, or gender‑affirming surgeries for U.S. citizens or lawful permanent resident minors; professional bodies such as WPATH; and the State Department’s consular and adjudicative processes.
Why It Matters
The bill uses immigration tools to regulate foreign medical practice directed at U.S. minors, tying professional association membership to admissibility and creating extraterritorial effects on health care access and international medical cooperation. Compliance officers, consular officials, and foreign medical providers will see operational and diplomatic consequences if the measure is implemented.
More articles like this one.
A weekly email with all the latest developments on this topic.
What This Bill Actually Does
The core mechanism is straightforward: the President must impose visa sanctions on any foreign person the administration determines performed or facilitated certain chemical or surgical interventions on U.S. minors. The text explicitly lists three categories that trigger sanctions: WPATH membership; licensed physicians who performed, prescribed, or otherwise facilitated those interventions for United States persons under 18; and owners or operators of foreign medical institutions that perform or facilitate such care.
Once designated, the person becomes inadmissible and ineligible for visas or other immigration benefits.
Sanctions have immediate force: the bill requires automatic revocation of any existing visas or entry documents for designated persons. The Secretary of State must create a process for individuals to submit information identifying foreign persons who meet the criteria.
At the same time the statute contains limited exceptions: the international‑obligations exception (for U.N. and other treaty obligations), a whistleblower exception for certain foreign clinicians who cease the prohibited conduct and provide actionable information, and a presidential waiver on national‑security grounds.The bill defines the prohibited interventions broadly as “chemical or surgical mutilation,” and explicitly lists puberty blockers (including gonadotropin‑releasing hormone agonists), sex hormones, and surgical procedures that alter sexual organs or external appearance. It carves out medical treatments for disorders of sexual development, treatment of complications arising from prohibited interventions, detransition care, and emergency or life‑saving care.
The statute also narrows the protected U.S. minor population to U.S. citizens and lawful permanent residents under 18, omits other foreign nationals present in the United States, and adopts a definition of “sex” as immutable and determined at conception.
The Five Things You Need to Know
The bill treats membership in the World Professional Association for Transgender Health (WPATH) as an independent basis for visa sanctions against a foreign person.
Designated foreign persons are made inadmissible, ineligible for visas and other immigration benefits, and subject to immediate automatic revocation of any existing U.S. visa or entry documentation.
The statutory definition of prohibited conduct—’chemical or surgical mutilation’—explicitly includes puberty blockers, cross‑sex hormones, and surgeries that alter sexual organs or external appearance, while excluding treatments for disorders of sexual development and detransition care.
The Secretary of State must accept public submissions identifying foreign persons and must report to Congress within 180 days on implementation and the number of people sanctioned; the President may also waive sanctions for national‑security reasons.
A whistleblower exception prevents sanctions for certain clinicians who stop the conduct and provide identifying information about other covered persons; however, the statute vests large factual discretion in the Secretary of State and the President.
Section-by-Section Breakdown
Every bill we cover gets an analysis of its key sections.
Short title
Provides the Act’s short name: the Protecting Children from Foreign Mutilation Act. This is a labeling provision with no operational effect beyond how the statute will be cited in later communications and guidance.
Who the President must sanction
Sets three discrete triggers for mandatory sanctions: (1) membership in WPATH; (2) licensed physicians who, in their professional capacity, performed, prescribed, or otherwise facilitated the listed interventions for United States minors; and (3) owners or operators of foreign clinics, pharmacies, hospitals, or medical institutions that perform or facilitate such care. Practically, the language reaches both individuals who provide care and entities that make that care available, and it ties designation to a presidential determination that can rely on submissions to State.
Visa and admission consequences; automatic revocation
Specifies the immigration penalties: designated foreign persons become inadmissible, ineligible for visas or documentation, and ineligible for admission or parole under the Immigration and Nationality Act. It also mandates immediate, automatic revocation of any existing visas or entry documents, with no statutory grace period or administrative stay. That places a heavy operational burden on consular posts and CBP to act on designations quickly and creates a bright‑line bar to future travel to the United States by designated persons.
Public submissions to State Department
Requires the Secretary of State to establish procedures for individuals to submit information identifying foreign persons who may meet the statutory criteria. This creates a formal intake channel for tip‑lines or disclosures from families, advocacy groups, or other actors and likely affects how records and allegations are triaged for potential designation.
Exceptions and waiver: international obligations, whistleblowers, presidential waiver
Carves out two statutory exceptions and one discretionary waiver: (1) an exception to comply with international agreements (explicitly including U.N. Headquarters Agreement), (2) a whistleblower exception that shields certain foreign physicians from sanctions if they cease the conduct and provide actionable identifying information, and (3) a presidential waiver where the President finds a national security justification. The whistleblower path requires administrative determinations by State and conditions the exception on both cessation of activity and provision of information.
Reporting to Congress
Directs the Secretary of State to report to Congress within 180 days on actions taken to implement the Act, the number of sanctioned people, and recommended additional measures to discourage foreign persons from providing the covered treatments to U.S. persons. The short reporting deadline pushes State to develop operational metrics and produce a public accounting early in implementation.
Key definitions and their reach
Defines ‘chemical or surgical mutilation’ to include puberty blockers, sex hormones, and surgeries intended to alter sexual organs or external appearance, while excluding care for disorders of sexual development, treatment of complications from interventions, detransition treatment, and emergency or life‑saving care. It defines ‘United States person’ narrowly (citizens and lawful permanent resident minors under 18), ‘foreign person’ as non‑U.S. citizens, and ‘sex’ as immutable at conception. Those lexical choices control who is protected and who is targeted and will be determinative in implementation and litigation.
Severability
States that if any provision is found unconstitutional, the rest of the Act remains effective. This typical clause preserves the remainder of the statute if courts strike particular provisions, but it also invites litigation strategies that will test individual definitional and procedural provisions rather than the statute as a whole.
This bill is one of many.
Codify tracks hundreds of bills on Immigration across all five countries.
Explore Immigration in Codify Search →Who Benefits and Who Bears the Cost
Every bill creates winners and losers. Here's who stands to gain and who bears the cost.
Who Benefits
- Parents or guardians seeking to prevent their U.S. citizen or LPR children from obtaining gender‑affirming interventions abroad — the statute creates a federal lever to block foreign providers from treating those minors and may deter cross‑border care.
- State governments and policymakers that restrict gender‑affirming care — they gain an extraterritorial enforcement tool that reduces the availability of foreign providers to U.S. minors subject to state restrictions.
- Advocacy organizations and constituencies that oppose gender‑affirming medical interventions for minors — the law formalizes a federal mechanism aligned with their policy goals and creates a public process (tips to State) to identify foreign actors.
- Families and individuals who pursue detransition or treatment for complications — the statute’s explicit exclusion for detransition treatment and for treatment of complications preserves a legal path for those services where needed.
Who Bears the Cost
- Foreign licensed clinicians, surgeons, and other medical personnel who are WPATH members or who provide puberty suppression, cross‑sex hormones, or surgeries to U.S. citizen/LPR minors — they face inadmissibility and immediate visa revocation if designated.
- Foreign medical institutions, clinics, pharmacies, and owners/operators that provide or facilitate the listed interventions to U.S. minors — these entities face reputational, operational, and personnel impacts and may see a loss of U.S. patient flow and professional exchange.
- U.S. Department of State and consular posts — they must stand up intake procedures, evaluate submissions, make fact‑intensive determinations, and execute immediate visa revocations, increasing workload and evidentiary challenges.
- U.S. foreign relations and international health cooperation — governments, multilateral bodies, and international medical associations risk diplomatic friction or reciprocal actions if their professionals are designated, potentially constraining collaboration on broader health issues.
Key Issues
The Core Tension
The bill pits a goal many supporters frame as protecting children from medical interventions against the realities of extraterritorial regulation: protecting minors by cutting off foreign providers risks sweeping in legitimate medical practice, using professional affiliation as guilt, and imposing diplomatic and procedural costs with limited procedural safeguards — a trade‑off between protective aims and the legal, evidentiary, and foreign‑policy consequences of enforcing those aims through visa exclusion.
The statute combines sweeping substantive definitions with immigration enforcement tools, which raises three operational and legal frictions. First, the definition of prohibited conduct—’chemical or surgical mutilation’—is both broad and prescriptive: it lists common, evidence‑based medical treatments (puberty blockers, sex hormones, certain surgeries) and ties their prohibition to an age‑based category of U.S. persons.
That creates immediate line‑drawing problems in cross‑border cases where clinical standards, informed consent, and parental authorization vary. Second, membership in a professional association (WPATH) is an independent statutory trigger.
Using association membership as a proxy for wrongdoing risks overbreadth and will likely draw constitutional and administrative‑law challenges, because it treats affiliation as evidence of culpability rather than requiring individualized proof of misconduct.
Third, the bill’s enforcement model concentrates discretionary power in executive determinations while providing limited procedural protections and significant diplomatic exposure. The Secretary of State is required to accept submissions and the President makes the designation, but the statute lacks detailed evidentiary or notice requirements, appeal paths, or timelines for review.
The provision referencing a private right of action in an exclusion appears to cite a non‑existent Section 4, a drafting inconsistency that raises questions about legislative intent. Those drafting gaps amplify litigation risk and complicate interagency implementation, consular decisionmaking, and foreign relations.
Try it yourself.
Ask a question in plain English, or pick a topic below. Results in seconds.